Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Go back to Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
(NASDAQ: TBPH) Delayed: 16.93 -0.05 (0.29%)
Previous Close $16.98    52 Week High $38.92 
Open $17.00    52 Week Low $12.87 
Day High $17.02    P/E N/A 
Day Low $16.93    EPS $0.00 
Volume 1,619,570